ArticleExercise, sport & movement2027
Changes in Hormone Cycles and Exercise Capacity During Testosterone Therapy in a Transmasculine Triathlete: A Case Study.
Article in Exercise, sport & movement, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The impact of testosterone therapy on the hormone cycles, exercise capacity, and physiology of transmasculine individuals is not well understood. Existing studies report limited metrics at large time intervals between data collection points. Methods: High-resolution temporal data were collected from a single amateur trans male triathlete over 13 months-including one baseline month and 12 months on testosterone therapy-to characterize hormone, strength, body composition, aerobic, and training load profiles. Results: Daily urine hormone monitoring revealed that progesterone and luteinizing hormone are the clearest metrics associated with cessation of menses. After 1 yr, the participant increased lean body mass by 12%, average hand grip strength by 16%, jump height by 16%, and average knee isometric strength by 18%, but did not lose fat mass or show changes in isokinetic knee strength. Fluctuations in running fitness and maximum oxygen consumption ( Conclusion: This study provides the most comprehensive characterization of the impacts of testosterone therapy on hormone cycles, exercise capacity, and physiological changes in a single person to date, as well as observations to help inform the design of larger cohort studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.